OxyPrem AG
1 known investors
OxyPrem develops non-invasive sensors that provide real-time monitoring of oxygen levels in human tissue, aimed at neonatal intensive care and the treatment of premature and other vulnerable patients. Its technology targets clinical teams, with an early focus on the Swiss NICU market.
Investors · 1
Frequently asked questions
- What does OxyPrem AG do?
- OxyPrem develops non-invasive sensors that provide real-time monitoring of oxygen levels in human tissue, aimed at neonatal intensive care and the treatment of premature and other vulnerable patients. Its technology targets clinical teams, with an early focus on the Swiss NICU market.
- Who are OxyPrem AG's investors?
- OxyPrem AG's investors include Capital Cell.